Results 231 to 240 of about 222,704 (323)
Relative Effectiveness of Cognitive Behavior Therapy, Antipsychotics and the Combination for People with First Episode Psychosis: A Two-Study Pooled Analysis of Individual Participant Data. [PDF]
Morrison AP +5 more
europepmc +1 more source
Abstract Social services for the elderly are becoming increasingly important in societies where the elderly population is growing and requires specific attention to ensure their well‐being. Within these services, nursing homes play a key role, and it is therefore vital to ensure efficient management with an assessment according to their characteristics,
Georgina Solaz‐Moreno +2 more
wiley +1 more source
Psychopharmacology in Dermatology. [PDF]
Katamanin O, Sharifi S, Jafferany M.
europepmc +1 more source
Understanding excessive sleep in people with psychotic disorders
Abstract Background There has been increasing attention to sleep disturbances such as insomnia in psychosis, due to its impact on symptoms, well‐being, and recovery. However, excessive sleep and extended sleep duration are common in psychosis (partly linked to sedating antipsychotic medication) and have been relatively neglected, despite plausible ...
Kate Robbins +2 more
wiley +1 more source
Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence. [PDF]
Radha Krishnan RP +3 more
europepmc +1 more source
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody +5 more
wiley +1 more source
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander +5 more
wiley +1 more source
First-generation antipsychotic shortages in the United States: Utilization and switching patterns. [PDF]
Tabah A, Swamy N, English C.
europepmc +1 more source
Holistic approach to substance‐induced psychosis
Addiction, EarlyView.
Julia M. Lappin +2 more
wiley +1 more source
Abstract Background and Purpose Subsets of midbrain dopamine (DA) neurons express the vesicular glutamate transporter VGLUT2 and can release the excitatory neurotransmitter glutamate. VGLUT2+ DA neurons of the substantia nigra pars compacta (SNc) were shown to be more resistant to neurodegeneration in animal models of Parkinson's disease (PD ...
Sivakumar Srinivasan +2 more
wiley +1 more source

